4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000010
Chief Financial Officer sold 13,400 shares at $13.53 ($181,258)
- Chief Financial Officer acquired 13,400 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2026-09-28 | Option exercise 10b5-1 | +13,400 | $4.36 | $58,424 | 83,228 | D: show line 1 in the form |
| Piscitelli Dominic Chief Financial Officer | 2026-09-28 | Sale 10b5-1 | −13,400 | $13.53 | $181,258 | 69,828 | D: show line 2 in the form |
| Open-market sales · 13,400 sh · avg $13.53 · $181,258 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2026-09-28 | Option exercise · Stock Option (right to buy) 10b5-1 | −13,400 | 78,500 | D: show line 3 in the form |
Loading xslF345X06/form4-09292026_110919.xml…